Nephrostomy Devices Market Report 2026

Nephrostomy Devices Market Overview

• Nephrostomy Devices market size has reached to $1.3 billion in 2025 • Expected to grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: The Rise In The Incidence Of Kidney Transplants Increasing Procedural Demand For Nephrostomy Devices • Market Trend: Innovative Multi Layered Catheter Safety Solutions Enhancing Patient Care And Comfort • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nephrostomy Devices Market?

Nephrostomy devices are medical instruments used to create and maintain an artificial passage between the kidney and the skin's surface to allow urine drainage. These devices are essential in managing conditions such as kidney stones, tumors, or strictures that obstruct the urinary flow, providing temporary or long-term relief of symptoms and preserving kidney function. The main product types of nephrostomy devices are guidewires, drainage tubes, nephrostomy catheters, sheath dilators, and others. Guidewires are thin, flexible wires that help guide catheters or other medical devices into place within the body during a nephrostomy procedure. They are used for various applications including kidney diseases, urological cancer and benign prostatic hyperplasia (BPH), other applications by hospitals, clinics, ambulatory surgical centers (ASCs), and other end-users.

What Is The Nephrostomy Devices Market Growth Forecast?

The nephrostomy devices market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing burden of urological cancers, increasing adoption of minimally invasive urology procedures, rising geriatric population with renal disorders, expansion of ambulatory surgical centers, increasing demand for long-term urinary drainage solutions. Major trends in the forecast period include growing adoption of percutaneous nephrostomy procedures, rising demand for minimally invasive urinary drainage solutions, increasing use of hydrophilic and coated nephrostomy devices, expansion of image-guided nephrostomy interventions, growing focus on patient comfort and infection prevention.

Global Nephrostomy Devices Market Segmentation

1) By Product Type: Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators, Other Products 2) By Application: Kidney Diseases, Urological Cancer And Benign Prostatic Hyperplasia (BPH) 3) By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), Other End-Users Subsegments: 1) By Guidewires: Straight Guidewires, Hydrophilic Guidewires, Coated Guidewires 2) By Drainage Tubes: Single-Lumen Drainage Tubes, Double-Lumen Drainage Tubes 3) By Nephrostomy Catheters: Percutaneous Nephrostomy Catheters, Suprapubic Nephrostomy Catheters 4) By Sheath Dilators: Standard Sheath Dilators, Hydrophilic Sheath Dilators 5) By Other Products: Nephrostomy Bags, Catheter Fixation Devices, Nephrostomy Kits

What Is The Driver Of The Nephrostomy Devices Market?

The rise in the incidence of kidney transplants is expected to propel the growth of the nephrostomy device market going forward. A kidney transplant is a surgical procedure in which a healthy kidney from a donor is placed in a person with kidney failure. The increase in kidney transplants is due to the growing incidence of chronic kidney disease and kidney failure and advancements in medical technology and transplant procedures. Nephrostomy devices help in kidney transplants by providing a temporary solution to drain urine directly from the kidneys when there are complications, such as blockages in the urinary tract, ensuring proper kidney function and reducing the risk of infection or damage to the transplanted kidney during the critical post-transplant recovery period. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit organization, there was a modest rise in kidney transplants, reaching 27,759 in 2024, an increase of 1.6 percent compared to 2023. In contrast, the number of heart transplants remained nearly the same, with 4,572 procedures in 2024 compared to 4,545 in 2023.Therefore, the rise in the incidence of kidney transplants is driving the growth of the nephrostomy devices industry.

Key Players In The Global Nephrostomy Devices Market

Major companies operating in the nephrostomy devices market are Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Coloplast Corp., B Braun Medical Inc., Cook Medical, Teleflex Incorporated, Merit Medical Systems, AngioDynamics, Argon Medical Devices, Well Lead Medical Co Ltd, Amecath, Medi-Globe GmbH, Troge Medical GmbH, Rocamed, Suru International Pvt Ltd, UroMed, Electramed Ltd, Urovision Urotech, Manfred Sauer UK, Surgimedik Healthcare India Pvt Ltd

Global Nephrostomy Devices Market Trends and Insights

Major companies operating in the nephrostomy devices market are focusing on developing advanced solutions, such as multi-layered catheter safety innovations, to replace traditional catheter stabilization methods. An advanced solution refers to a technology that improves patient safety by reducing the risk of infections, accidental dislodgement, and discomfort. For instance, in November 2025, Cathetrix Ltd a US-based developer of smart catheter stabilisation devices, launched Nephro-Safe, the world’s most advanced nephrostomy tube stabiliser, under its new subsidiary TubeX. This innovation replaces traditional stabilization methods by providing a dual-layer protection system, including a secure anchoring mechanism and smart anti-slide technology, which prevents external forces from affecting the nephrostomy site. Integrated with Cathetrix’s Foley-Safe catheter stabiliser, the solution offers a three-layer protection system for Foley catheters, addressing fixation, movement absorption, and safe disconnection. These innovations improve patient comfort, enhance safety, and simplify catheter management for caregivers.

What Are Latest Mergers And Acquisitions In The Nephrostomy Devices Market?

In October 2023, Laborie Medical Technologies Corp, a US-based diagnostic and therapeutic medical technology company, acquired Urotronic Inc for an undisclosed amount. With this acquisition, Urotronic and its employees will completely integrate into the Laborie business to provide innovative technologies that preserve and restore human dignity in interventional urology. Urotronic Inc is a US-based medical device company that offers a range of products, including nephrostomy devices.

Regional Outlook

North America was the largest region in the nephrostomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Nephrostomy Devices Market?

The nephrostomy devices market consists of sales of nephrostomy tubes, catheters, guidewires, dilators, sheaths, and drainage bags. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.